Dr. Gouri Shankar Bhattacharyya
Salt Lake City Medical Centre, Kolkata
Biography
Dr. GS Bhattacharyya is Medical Oncologist at Salt Lake City Medical Centre, Kolkata.
He has been conferred with FAcadTM, F-ASPET, RCOG Associate, Fellow American College Clinical Pharmacology. Completed education and training Medical Oncology from England. His interest Biological Response Modifiers and Tumour Microenvironment, Special interest in Palliative Care and Geriatric Oncology, Cancer Research and Delivery of Cost-Effective Cancer Care and repurposing of drugs.
Past President of ISMPO. Member of the ASCO, ESMO (Global Policy Committee Member), Global Cancer Task Force, ESMO Global Opioid Policy Initiative Coordinator, ESMO-EAPC Joint Executive Committee, WHO Steering Committee for Development of a Medical Devices List for Cancer Management.Holder of Orphan Drug status with FDA for Hepatocellular carcinoma, Pancreatic Cancer and Glioma. He is Editorial Board Member, Reviewer and Publication Committee Member of many International and National Journals. He has been awarded Certificate of recognition for Promotion and Development of Palliative Care in the World in 2013, by IAHPC. Executive Council Member of International Cardi-Oncological Society (ICOS). ESMO Designated Centre of Integrated Oncology and Palliative Care. He is Advisory Board Member to DCGI; Faculty Member to Clinical Development Services Agency (CDSA) and Department of Biotechnology (DBT); NCI-NIH, USA Task Force Member for Gastrointestinal cancer and Hepatobiliary cancer; Member of Global mBC Taskforce and Global Advanced Breast Cancer Alliance. Published more than 200 papers and has been an Investigator for more than 50 Phase II and III Clinical Trials and Translational Research.
He has been conferred with FAcadTM, F-ASPET, RCOG Associate, Fellow American College Clinical Pharmacology. Completed education and training Medical Oncology from England. His interest Biological Response Modifiers and Tumour Microenvironment, Special interest in Palliative Care and Geriatric Oncology, Cancer Research and Delivery of Cost-Effective Cancer Care and repurposing of drugs.
Past President of ISMPO. Member of the ASCO, ESMO (Global Policy Committee Member), Global Cancer Task Force, ESMO Global Opioid Policy Initiative Coordinator, ESMO-EAPC Joint Executive Committee, WHO Steering Committee for Development of a Medical Devices List for Cancer Management.Holder of Orphan Drug status with FDA for Hepatocellular carcinoma, Pancreatic Cancer and Glioma. He is Editorial Board Member, Reviewer and Publication Committee Member of many International and National Journals. He has been awarded Certificate of recognition for Promotion and Development of Palliative Care in the World in 2013, by IAHPC. Executive Council Member of International Cardi-Oncological Society (ICOS). ESMO Designated Centre of Integrated Oncology and Palliative Care. He is Advisory Board Member to DCGI; Faculty Member to Clinical Development Services Agency (CDSA) and Department of Biotechnology (DBT); NCI-NIH, USA Task Force Member for Gastrointestinal cancer and Hepatobiliary cancer; Member of Global mBC Taskforce and Global Advanced Breast Cancer Alliance. Published more than 200 papers and has been an Investigator for more than 50 Phase II and III Clinical Trials and Translational Research.